患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

• 進捗状況
• 試験名
• 対象疾患名
• 地域
• 登録日
•  

• Not Recruiting

• A 25 month study of a potential new medicine (GSK1605786A) for the treatment of Crohn’s disease
• Subjects with Crohn’s Disease MedDRA version: 16.1 Level: PT Classification code 10011401 Term: Crohn's disease System Organ Class: 10017947 - Gastrointestinal disorders ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
• Australia, Austria, Belgium, Bulgaria, Canada, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Italy, Japan, Netherlands, Norway, Poland, Portugal, Slovakia, Spain, Sweden, United Kingdom, United States
• 2010-11-10

• Not recruiting

• Assessing Childbirth-related Complications at the Community Level in Kenya
• Puerperal Sepsis;Postpartum Hemorrhage;Preeclampsia and Eclampsia;Retained Placenta, Without Hemorrhage;Obstructed Labor Due to Breech Presentation
• Kenya
• 2012-08-09

• Not Recruiting

• An international study to assess the safety and efficacy of a combination of new investigational drugs in hepatitis C virus infected patients with advanced liver disease or require treatment after liver transplantation.
• Chronic Genotype 1 and Genotype 4 Hepatitis C Virus Infection MedDRA version: 17.0 Level: LLT Classification code 10019751 Term: Hepatitis C virus System Organ Class: 100000004848 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
• Australia, Austria, Belgium, Canada, France, Germany, Italy, Netherlands, New Zealand, Spain, Switzerland, United Kingdom
• 2013-10-31

• Not recruiting

• Transthoracic echocardiography and ophthalmic artery Doppler measurements in pregnant women
• Hypertension;Preeclampsia;Human immunodeficiency virus (HIV);Pregnancy
• South Africa
• 2013-09-05

• Not Recruiting

• Treatment with Rosuvastatin versus switching PI (protease inhibitor) in patients HIV with high cholesterol levels.
• HIV AND HYPERCHOLESTEROLAEMIA MedDRA version: 16.0 Level: LLT Classification code 10068341 Term: HIV-1 infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
• Australia, Spain
• 2013-07-12

• Not recruiting

• Coadministration of Malignancy and Infection specific T cells after allogeneic stem cell Transplant for Acute Leukaemia with CD34+ selected stem cells
• Acute Leukaemia;Cytomegalovirus;Epstein-Barr Virus;Varicella Zoster Virus;BK Virus;Influenza virus;Aspergillus
• Australia
• 2018-06-29

• Not recruiting

• Bowel Preparation Assessment Using Ultrasound Examination II
• Crohn's disease;Ulcerative Colitis;Colonoscopy preparation;Inflammatory bowel disease;bowel preparation
• Australia
• 2018-04-20

• Not Recruiting

• Study to compare the efficacy of nevirapine given once daily versus nevirapine given twice daily both in combination with Truvada for the treatment of HIV-infection.
• HIV-1 infection MedDRA version: 14.0 Level: LLT Classification code 10020160 Term: HIV disease System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
• Argentina, Australia, Belgium, Botswana, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, Poland, Portugal, Romania, Russian Federation, South Africa, Spain, Switzerland, United Kingdom, United States
• 2007-09-10

• Not recruiting

• Human Papilloma Virus (HPV) Vaccination in Special Risk Groups
• Special Risk Groups 1. Paediatric Rheumatalogical Disease 2. Inflammatory Bowel Disease 3. Acute Lymphoblastic Leukaemia 4. Solid Organ Transplant Recipients (kidney and liver) 5. Chronic Renal Disease 6. Bone Marrow Transsplant The response to the HPV vaccine will be studied within these 6 special risk groups.
• Australia
• 2009-07-13

• Not recruiting

• Risk Stratified Sequential Treatment for CD20-positive PTLD
• PTLD;Posttransplant Lymphoproliferative Disorder;PTLD;Posttransplant Lymphoproliferative Disorder;PTLD;Posttransplant Lymphoproliferative Disorder;PTLD;Posttransplant Lymphoproliferative Disorder
• Australia, Belgium, France, Germany, Italy, Poland, Sweden
• 2007-12-28

• Not Recruiting

• A phase 3 clinical trial to compare the safety and effectiveness of GSK1349572 and abacavir/lamivudine compared to Atripla over 96 weeks in patients with HIV infection who have not previously received treatment.
• HIV-1 infected antiretroviral therapy naive adult subjects. MedDRA version: 14.1 Level: LLT Classification code 10008922 Term: Chronic infection with HIV System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
• Australia, Belgium, Canada, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, Romania, South Africa, Spain, United Kingdom, United States
• 2010-11-08

• Not recruiting

• Nutrition Education Intervention in Adults With Type 2 Diabetes Mellitus in a Resource Poor Setting
• Diabetes Mellitus, Type II [Non-insulin Dependent Type] [NIDDM Type] Uncontrolled
• South Africa
• 2010-03-29

• Not Recruiting

• A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q (MDS-005)
• TRANSFUSION-DEPENDENT ANEMIA DUE TO IPSS LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES WITHOUT DELETION 5Q [31] AND UNRESPONSIVE OR REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENT MedDRA version: 19.0 Level: LLT Classification code 10068361 Term: MDS System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
• Australia, Austria, Belgium, Czech Republic, France, Germany, Israel, Italy, Poland, Portugal, Spain, Turkey, United Kingdom
• 2009-10-05

• Not recruiting

• A Randomized, Controlled Study to Evaluate Algisyl-LVR™ as a Method of Left Ventricular Augmentation for Heart Failure
• Heart Failure;Dilated Cardiomyopathy;Heart Failure;Dilated Cardiomyopathy;Heart Failure;Dilated Cardiomyopathy;Heart Failure;Dilated Cardiomyopathy
• Australia, Germany, Italy, Netherlands, New Zealand, Romania
• 2011-03-08

• Not Recruiting

• A study in Patients with Diabetic Kidney Disease
• Patients with Diabetic Kidney Disease due to Type 1 or Type 2 Diabetes MedDRA version: 15.0 Level: LLT Classification code 10064848 Term: Chronic kidney disease System Organ Class: 10038359 - Renal and urinary disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
• Australia, Czech Republic, France, Hungary, Israel, Puerto Rico, United States
• 2011-01-31

• Not Recruiting

• MIA-002: A randomised, vaginal microbicide trial assessing the safety of PRO 2000/5 gel (P) versus vehicle placebo in Uganda
• HIV-1 Infections and Infestations Human immunodeficiency virus (HIV)
• Uganda
• 2005-09-15

• Not Recruiting

• Vitamin and mineral supplementation in reducing morbidity in Human Immunodeficiency Virus (HIV)-infected children in developing countries: an efficacy study
• Micronutrient supplementation of HIV-1-infected children Infections and Infestations Human Immunodeficiency Virus (HIV)
• South Africa
• 2007-12-07

• Not recruiting

• The impact of whole body heating on blood flow distribution and temperature regulation in chronic heart failure patients
• New York Heart Association Class I-III chronic heart failure (aetiology either ischaemic or idiopathic dilated cardiomyopathy)
• Australia
• 2013-04-05

• Not recruiting

• Move to the Music - the effect of music cues on walking in people with 2 types of progressive neurological disorder.
• Progressive Supranuclear Palsy;Alzheimer's Disease
• Australia
• 2016-06-29

• Not recruiting

• Glivec plus chemotherapy in blast-phase CML and Ph+ ALL
• Blast-Phase Chronic Myeloid Leukemia;Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
• Australia
• 2005-08-04